ERDERA Strategic Research and Innovation Agenda

The SRIA sets ERDERA’s objectives and performance indicators to guide rare disease research and innovation across Europe.

This Strategic Research and Innovation Agenda (SRIA) describes the SRIA development process and sets out the ambition, vision and mission of the European Rare Diseases Research Alliance (ERDERA). It defines ERDERA’s general, specific and operational objectives, and includes performance indicators for monitoring and evaluation.

Acces this publication

publication

cover for the ERDERA Strategic Research and Innovation Agenda (2024)

Source

ERDERA

You might also be interested in

ERDERA Ethics & Regulatory webinar series: The Role of Ethics in ATMP Research and Development

The Role of Ethics in ATMP Research and Development

November 2 @ 1:00 pm - 2:00 pm
ERDERA Ethics & Regulatory Webinar Series
Genetic Mapping

New clinical trial guidance supports research beyond the hospital

New international guidance supports decentralised clinical trials, pragmatic designs and the use of real-world data.
Irish Presidency of the EU in 2026

Why Rare Diseases Matter for Europe’s Future Embedding Research and Innovation as Standard of Care in Rare Disease

November 13 @ 10:00 am - 5:15 pm
On 13 November 2026 in Dublin, Ireland, this event will explore how research, innovation, patient partnership and EU policy can improve rare disease care and strengthen Europe’s life sciences ecosystem.
European Medicines Agency (EMA)

EMA launches a new pilot to advance innovative methods to animal testing

The voluntary data submission framework allows developers to share data generated using New Approach Methodologies outside marketing authorisation applications and receive tailored, non-binding feedback from European regulatory experts.

ERDERA Search